REGN relationship map
REGN
Regeneron Pharmaceuticals, Inc.
REGN sells to Healthcare · 8
REGNRegeneron Pharmaceuticals, Inc.
Healthcare8 · open
ACETAdicet Bio2°City of Hopeunlisted
BHVNBiohaven2°Ypsomedunlisted
2°GeneQuantum Healthcareunlisted
2°Hangzhou Highlightll Pharmaceuticalunlisted
IMRXImmuneering2°BioArkiveunlisted
2°Aventisunlisted
KNSAKiniksa Pharmaceuticals International2°Samsungunlisted
2°Huadongunlisted
2°Genentechunlisted
RAREUltragenyx Pharmaceutical2°Kyowa Kirinunlisted
2°Undisclosed supplierunnamed in filing
2°KKCunlisted
REPLReplimune2°Rocheunlisted
2°United Kingdom governmentunlisted
UPBUpstream Bio2°Astellas Pharmaunlisted
2°Maruhounlisted
2°Lonza Salesunlisted
—Kiniksa Pharmaceuticalsunlisted
Industrials & materials4 ›Sells to →
100.00% of ACET rev10-K
2°City of Hopeunlisted
2°BX Bodyguard Royaltiesunlisted
2°Rocheunlisted
2°Scitheraunlisted
2°Art Acquisition Subunlisted
2°SparingVision SASunlisted
2°AvenCell Therapeuticsunlisted
2°Alcamiunlisted
BA Leasing BSCunlisted—
Bank of America, N.Aunlisted—
Bayerunlisted—
E. R. Squibb & Sonsunlisted—
Ono Pharmaceuticalunlisted—
Sanofiunlisted—
Santenunlisted—
Sonoma Biotherapeuticsunlisted—
← Buys from
REGNRegeneron Pharmaceuticals, Inc.
2°City of Hopeunlisted
2°Ypsomedunlisted
2°GeneQuantum Healthcareunlisted
2°Hangzhou Highlightll Pharmaceuticalunlisted
2°BioArkiveunlisted
2°Aventisunlisted
2°Samsungunlisted
2°Huadongunlisted
2°Genentechunlisted
2°Kyowa Kirinunlisted
2°Undisclosed supplierunnamed in filing
2°KKCunlisted
2°Rocheunlisted
2°United Kingdom governmentunlisted
2°Astellas Pharmaunlisted
2°Maruhounlisted
2°Lonza Salesunlisted
—Kiniksa Pharmaceuticalsunlisted
Sells to →
suppliercustomerunlisted2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 20:34 ETSources